Search - tctmd.com

Displaying 701 - 720 of 2532

Sort: Relevancy | Date

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

November 17, 2020

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

November 11, 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

November 11, 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

November 09, 2020

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

News Daily News

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

November 04, 2020

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

News Daily News

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

November 03, 2020

November 2020 News Roundup

News Opinion CV Team Dispatch

November 2020 News Roundup

November 01, 2020

COVID-19: TCTMD’s Daily Dispatch for November

News

COVID-19: TCTMD’s Daily Dispatch for November

November 01, 2020

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

New Review Urges Rethink of Cardiogenic Shock Care

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

October 27, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

October 18, 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

News Conference News TCT 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

October 18, 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presentation TCT 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presenter: Ehrin J. Armstrong

October 18, 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presentation TCT 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presenter: Ehrin Armstrong

October 18, 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

October 17, 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

October 16, 2020

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.